Q2 2026 Earnings Call August 6, 2026 4:30 PM EDTCompany ParticipantsMichael Nuzzo - CEO & DirectorRobert Julian ...
Health Catalyst provides forward-looking guidance on total revenue, a GAAP measure, and Adjusted EBITDA, a non-GAAP measure. For the third quarter of 2026, we expect: Adjusted EBITDA of $0 to $0.5 ...
Q2 2026 earnings call recap: record ACV, revenue and royalties, raised FY26 revenue guidance, and Cycuity-Arm momentum—read key takeaways.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results